Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
We've identified the following companies as similar to ALK-Abello B because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
| Name | Ticker | Consensus Recommendation |
|---|---|---|
| Indivior | DB:2IVB | - |
| Orion Oyj A | HLSE:ORNAV | - |
| Sopharma | BUL:SFA | 1.00 |
| Almirall | BME:ALM | 1.30 |
| COSMO Pharmaceuticals SA | SWX:COPN | 1.33 |
| Healthcare | SECTOR:HLTH.DK | 1.41 |
| Zealand Pharma A/S | CPSE:ZEAL | 1.46 |
| ALK-Abello B | CPSE:ALKB | 1.50 |
| Genmab | CPSE:GMAB | 1.95 |
| Recordati | BIT:REC | 2.60 |
| Faes Farma SA | BME:FAE | 3.00 |
| Euroapi SAS | ENXTPA:EAPI | 4.00 |
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Consensus Recommendation in the predictions category include:
Represents the opinions expressed by analysts on the stock performance over a short-term period. Recommendations are standardized across analysts on a...
The chart above depicts the distribution of Consensus Recommendation for companies operating in the Healthcare Sector in the Developed economic region. Over 2,090 companies were considered in this analysis, and 2,055 had meaningful values. The average Consensus Recommendation of companies in the Sector is 1.54 with a standard deviation of 0.87. Please note that Sector and Industry values may differ from other sources, as no adjustments have been made.
ALK-Abello B's Consensus Recommendation of 1.50 ranks in the 50.0% percentile for the Sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,097 |
| Included Constituents | 2,055 |
| Min | 0.00 |
| Max | 3.43 |
| Median | 1.50 |
| Mean | 1.54 |
| Standard Deviation | 0.87 |
You can find companies with similar Consensus Recommendation using this stock screener.